Article

Anti-inflammatory effects of benfotiamine are mediated through the regulation of the arachidonic acid pathway in macrophages.

Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555, USA.
Free Radical Biology and Medicine (Impact Factor: 5.27). 10/2011; 52(1):182-90. DOI: 10.1016/j.freeradbiomed.2011.10.444
Source: PubMed

ABSTRACT Benfotiamine, a lipid-soluble analogue of vitamin B1, is a potent antioxidant that is used as a food supplement for the treatment of diabetic complications. Our recent study (U.C. Yadav et al., Free Radic. Biol. Med. 48:1423-1434, 2010) indicates a novel role for benfotiamine in the prevention of bacterial endotoxin, lipopolysaccharide (LPS)-induced cytotoxicity and inflammatory response in murine macrophages. Nevertheless, it remains unclear how benfotiamine mediates anti-inflammatory effects. In this study, we investigated the anti-inflammatory role of benfotiamine in regulating arachidonic acid (AA) pathway-generated inflammatory lipid mediators in RAW264.7 macrophages. Benfotiamine prevented the LPS-induced activation of cPLA2 and release of AA metabolites such as leukotrienes, prostaglandin E2, thromboxane 2 (TXB2), and prostacyclin (PGI2) in macrophages. Further, LPS-induced expression of AA-metabolizing enzymes such as COX-2, LOX-5, TXB synthase, and PGI2 synthase was significantly blocked by benfotiamine. Furthermore, benfotiamine prevented the LPS-induced phosphorylation of ERK1/2 and expression of transcription factors NF-κB and Egr-1. Benfotiamine also prevented the LPS-induced oxidative stress and protein-HNE adduct formation. Most importantly, compared to specific COX-2 and LOX-5 inhibitors, benfotiamine significantly prevented LPS-induced macrophage death and monocyte adhesion to endothelial cells. Thus, our studies indicate that the dual regulation of the COX and LOX pathways in AA metabolism could be a novel mechanism by which benfotiamine exhibits its potential anti-inflammatory response.

0 Bookmarks
 · 
149 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Clinical evidence demonstrates that ubiquinol-10, the reduced active form of Coenzyme Q10 (CoQ10H2), improves endothelial function through its antioxidant and likely anti-inflammatory properties. We previously reported that a biomarker combination including miR-146a, its target protein IL-1 receptor-associated kinase (IRAK-1), and released interleukin (IL)-6, here collectively designated as MIRAKIL, indicates senescence-associated secretory phenotype (SASP) acquisition by primary human umbilical vein endothelial cells (HUVEC). We explore the ability of short- and long-term CoQ10H2 supplementation to affect MIRAKIL in HUVEC, used as a model of vascular aging, during replicative senescence in absence/presence of lipopolysaccharide (LPS), a proinflammatory stimulus. Senescent HUVEC had the same ability as young cells to internalize CoQ10 and exhibit an improved oxidative status. LPS-induced NF-κB activation diminished after CoQ10H2 pretreatment both in young and senescent cells. However, short-term CoQ10H2 supplementation attenuated LPS-induced MIRAKIL changes in young cells; in senescent cells CoQ10H2 supplementation significantly attenuated LPS-induced miR-146a and IRAK-1 modulation but failed to curb IL-6 release. Similar results were obtained with long-term CoQ10H2 incubation. These findings provide new insights into the molecular mechanisms by which CoQ10H2 stems endothelial cell inflammatory responses and delays SASP acquisition. These phenomena may play a role in preventing the endothelial dysfunction associated with major age-related diseases.
    Free Radical Biology and Medicine 05/2013; · 5.27 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Vitamin E is a fat–soluble agent protecting cells from free radicals damages. Previous studies have shown that oxidative stress plays an important role in mucosal intestinal damages in burn trauma. This study aimed to investigate vitamin E effects on small intestinal mucosal changes in burned rats. Methods: Mature male rats (n=32) weighing 260 ± 10 g were used in this experiment. After induction of deep general anesthesia, a determined area of rats’ back region (10% of body surface) was exposed to 95oC water for 8 seconds to induce a second-degree wet burn. The evaluated groups in our study were: 8 rats without burning, 8 rats without burning treated with vitamin E, 300 mg/kg/day for 15 days, 8 burned rats without medication and 8 burned rats treated with vitamin E, 300 mg/kg/day for 15 days. All rats were killed on fifteenth day by ether inhalation. The samples were taken from the first part ofsmallintestineandwerestainedbyHematoxylin&Eosinmethod. Results:Burned rats receiving vitamin E had a higher intestinal villi height and lower intestinal lumen diameter as compared to burned rats without the vitamin E treatment (P < 0.05 and P < 0.01, respectively) and those values were close to the results of unburned ones. There were no significant differences among the study groups regarding the intestinal diameter and muscular layer thickness. Conclusion: Vitamin E can improve intestinal villus height and lumen diameter and its consumption at the time of burning may protect intestine mucosa.
    Pharmaceutical sciences. 01/2014; 19(3):83-90.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Vitamins are crucial components in the diet of animals and many other living organisms. One of these essential nutrients, thiamin, is known to be involved in several cell-functions, including energy-metabolism and the degradation of sugars and carbon skeletons. Other roles that are connected to this vitamin are neuronal communication, immune system activation, signaling and maintenance processes in cells and tissues and cell-membrane dynamics. Because of the key functions thiamin has, uptake and transport through the body are crucial. Its uptake route is relatively complex encompassing a variety of protein families, including the solute carrier (SLC) anion transporters, the alkaline phosphatase (ALP) transport system and the human extraneuronal monoamine transporter (hEMT) family, some of which are multi-specific proteins. There are two known structures of protein (subunits) involved in thiamin uptake in prokaryotes. Binding of thiamin to these proteins is strongly guided by electrostatic interactions. The lack of structural information on thiamin binding proteins for higher organisms remains a bottleneck for understanding the uptake process of thiamin in atomic detail. This review includes recent data on thiamin metabolism, related deficiencies and pathologies, and the latest findings on thiamin binding transporters.
    Biochemistry 01/2014; · 3.38 Impact Factor

Preview

Download
0 Downloads
Available from